A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2b, randomized, double blind, placebo and active controlled study with an
Ascending Dose Stage and an optional Dose Expansion Stage in subjects undergoing open
inguinal herniorrhaphy with mesh.